138
Views
55
CrossRef citations to date
0
Altmetric
Original Research

Moderate and severe plaque psoriasis: cost-of-illness study in Italy

, , , , , , , , & show all
Pages 559-568 | Published online: 11 Apr 2008

References

  • AltobelliEMaccaroneMPetrocelliRAnalysis of health care and actual needs of patients with psoriasis: a survey on the Italian populationBMC Public Health200775917448249
  • ApoloneGMosconiPWareJEJQuestionario sullo stato di salute SF-36. Mauale d’uso e guida all’interpretazione dei risultati. Guerini e Associati1997
  • Banca d’ItaliaItalian household budgets in year 20022006 [online] Accessed Febr 2006. URL: http://www.bancaditalia.it/pubblicazioni
  • BergerKEhlkenBKuglandBCost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in GermanyJ Dtsch Dermatol Ges20053511815967010
  • BoehnckeSThaciDBeschmannHPsoriasis patients show signs of insulin resistanceBr J Dermatol200715712495117916217
  • BraathenLRCost of caring for hospital-based patients in dermatology in EuropeJ Eur Acad Dermatol Venereol20011529211730032
  • DehkharghaniSBibleJChenJGThe economic burden of skin disease in the United StatesJ Am Acad Dermatol200348592912664024
  • Del GiglioMGisondiPGirolomoniGThe need for long-term continuous therapyin moderate to severe chronic plaque psoriasisG Ital Dermatol Venereol200714226981
  • EghlilebAMDaviesEEGFinlayAYPsoriasis has a major secondary impact on the lives of family members and partnersClinical and Laboratory Investigation200710.1111/j.1365-2133.2007.07881.x
  • FeldmanSRFleischerABReboussinDMThe economic impact of psoriasis increases with psoriasis severityJ Am Acad Dermatol19973756499344194
  • FinlayAYCurrent severe psoriasis and the Rule of TensBr J Dermatol2005152861715888138
  • FinlayAYKhanGKDermatology Life Quality Index (DLQI): A simple practical measure for routine clinical useClin Exp Dermatol199419210168033378
  • FinlayAYPsoriasis from the patient’s point of viewArch Dermatol2001137352311255339
  • FinlayAYSkin disease disability: measuring its magnitudeKeio J Med19984713149785757
  • FinziAFMantovaniLGBelisariAThe expenses of hospital-related care of patients with psoriasis in Italy based on the AISP studyJ Eur Acad Dermatol Venereol200115320411730042
  • GaladariIRigelELebwohlMThe cost of psoriasis treatmentJ Eur Acad Dermatol Venereol200115320411730042
  • GelfandJMGladmanDDMeasePJEpidemiology of psoriatic arthritis in the population of the United StatesJ Am Acad Dermatol20055357316198775
  • GelfandJMNeimannALShinDBRisk of myocardial infarction in patients with psoriasisJAMA200629617354117032986
  • GisondiPGirolomoniGSampognaFPrevalence of psoriatic arthritis and jot complaints in large population of Italian patients hospitalized for psoriasisEur J Dermatol2005152798316048759
  • GisondiPGirolomoniGAggiornamento sui trattamenti biologici della psoriasiG Ital Dermatol Venereol2007142Suppl 1111
  • GisondiPTessariGContiAPrevalence of metabolic syndrome in patients with psoriasis: a hospital based case-control studyBr J Dermatol2007157687317553036
  • GriffithsEMCBarkeJNWNPathogenesis and clinical features of psoriasisLancet20073702637117658397
  • Health MinistryNomenclatore delle Prestazioni di assistenza specialistica ambulatoriale. Ministero della Salute2006 National Tariff Nomenclature2006a
  • Health MinistryHospital DRG tariffs2006bTariffa Unica Convenzionale, National DRG Tariff
  • HornEJFoxKMPatelVAssociation of patient-reported psoriasis severity with income and employmentJ Am Acad Dermatol2007579637117761358
  • Informatore Farmaceutico2007MedicinaliMasson-Elsevier
  • Italian inflation rates2007 [online] Accessed July 2007. URL: http://www.istat.it/prezzi/precon/rivalutazioni
  • JavitzHSWardMMFarberEThe direct cost of care for psoriasis and psoriatic arthritis in the United StatesJ Am Acad Dermatol2002468506012063481
  • JennerNCampbellJPlunkettACost of psoriasis: a study on the morbidity and financial effects of having psoriasis in AustraliaAustralas J Dermatol2002432556112423431
  • KimballABJacobsonCWeissSThe psychosocial burden of psoriasisAm J Clin Dermatol200563839216343026
  • KirbyBFortuneDGBhushanMThe Salford Psoriasis Index: an holistic measure of psoriasis severityBr J Dermatol20001427283210792223
  • KooJPopulation-based epidemiologic study of psoriasis with emphasis on quality of life assessmentDermatol Clin199614485968818558
  • LambergLDermatologic disorders diminish quality of lifeJAMA199727716639169878
  • LangleyRGEllisCNEvaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global AssessmentJ Am Acad Dermatol200451563915389191
  • MalerbaMGisondiPRadaeliAPsoriasis and risk of myocardial infarctionJAMA2007297361217244829
  • MalerbaMGisondiPRadaeliAPlasma homocysteine and folate levels in patients with chronic plaque psoriasisBr J Dermatol20061551165917107384
  • MallbrisLAkreOGranathFIncreased risk for cardiovascular mortality in psoriasis inpatients but not in outpatientsEur J Epidemiol2004192253015117115
  • MallbrisLAkreOStahleMMetabolic disorders in patients with psoriasis and psoriatic arthritisCurr Rheumatol Rep200683556316973109
  • MarchettiALapenseeKAnPA pharmacoeconomic analysis of topical therapies for patients with mild-tomoderate stable plaque psoriasis: a US studyClin Ther199820851699737842
  • NaldiLChatenaudLCastelliETrattamento della psoriasi con farmaci sistemici in Italia, Psocare, Primo Rapporto 20062006 [online] URL: http://www.psocare.it/epidemiologia.php
  • NaldiLColomboPBenedetti PlacchesiESutudy design and preliminary results from the pilot phase of the Praktis Study: Self-reported diagnoses of selected skin diseases in a representative sample of the italian populationDermatology2004208384214730235
  • NeimannALShinDBWangXPrevalence of cardiovascular risks factors in patients with psoriasisJ Am Acad Dermatol2006558293517052489
  • NevittGJHutchinsonPEPsoriasis in the community: prevalence, severity and patients’ beliefs and attitudes towards the diseaseBr J Dermatol199613553378915141
  • ParisierDMBagelJGelfandJMNational Psoriasis Foundation Clinical Consensus on Disease SeverityArch Dermatol20071432394217310004
  • PlunkettAMarksRA review of the epidemiology of psoriasis vulgaris in the communityAustralas J Dermatol199839225329838718
  • RappSRFeldmanSRExumMLPsoriasis causes as much disability as other major medical diseasesJ Am Acad Dermatol199941401710459113
  • SampognaFTabolliSSoderfeldtBMeasuring quality of life of patients with different clinical types of psoriasis using the SF-36Clinical and Laboratory Investigation200510.1111/j.1365-2133.2005.07071.x
  • SanderHMMorrisLFPhillipsCMThe annual expenses of psoriasisJ Am Acad Dermatol1993342258445058
  • SaracenoRMannheimerRChimentiSRegional distribution of psoriasis in ItalyJ Eur Acad Dermatol Venereol2008In press
  • ShapiroJCohenADDavidMThe association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control studyJ Am Acad Dermatol2007566293417157411
  • ShikiarRBresnahanBWStoneSPValidity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trialsHealth Qual Life Outcomes200315314613569
  • SohnSSchoeffskiOPrinzJCost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness studyDermatology20062121374416484820
  • SternRSEpidemiology of psoriasisDermatol Clin199513717228785877
  • SterryWBarkerJBoehnckeW-HBiological therapies in the systemic management of psoriasis: International Consensus ConferenceBr J Dermatol2004151Suppl 6931715265063